Concurrent Courses: Exploring the Synchronous Occurrence of Hepatic Myelolipoma and Hepatocellular Carcinoma

TL;DR

This case report describes a rare instance of a patient with both hepatic myelolipoma and hepatocellular carcinoma.

Contribution

The novelty lies in documenting a synchronous occurrence of hepatic myelolipoma and hepatocellular carcinoma, which is exceptionally rare.

Findings

A patient was found to have a massive hepatic myelolipoma along with hepatocellular carcinoma.

The patient underwent tumor resection following multidisciplinary team evaluation.

Abstract

Myelolipomas are benign, nonfunctioning neoplasms that most commonly arise in the adrenal glands and constitute a recognisable subset of adrenal masses. They are primarily composed of haematopoietic cells and fatty tissues. Hepatic myelolipoma is extremely rare, with only 11 cases previously recorded in English medical literature. It is usually an incidental finding. Hepatic myelolipomas are most often identified by ultrasound (US), computed tomography (CT) and magnetic resonance imaging (MRI), and diagnosis is confirmed with histopathology. In this case report, we describe an exceptionally uncommon case in which a patient presented with aberrant and nonspecific symptoms. He was discovered to have a massive hepatic myelolipoma, as well as elements of hepatocellular carcinoma (HCC). He underwent tumour resection after being carefully reviewed by the sarcoma multidisciplinary team (MDT).

Figures